<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03875365</url>
  </required_header>
  <id_info>
    <org_study_id>18-007834</org_study_id>
    <nct_id>NCT03875365</nct_id>
  </id_info>
  <brief_title>Institutional Outcome Data From Per-oral Plication of the Esophagus</brief_title>
  <official_title>Institutional Outcome Data From Per-oral Plication of the Esophagus (POPE)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Researchers are reviewing and analyzing surgical and clinical outcomes of subjects who
      underwent POPE for end-stage achalasia, a sigmoid esophagus, or a redundant conduit that has
      been used to replace the esophagus. This data will help researchers determine the safety and
      efficacy of a novel minimally invasive treatment compared to invasive surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Researchers will be collecting electronic medical data for subjects who have already
      undergone Per-oral Plication of the Esophagus (POPE) procedure. Subject characteristics,
      radiographic documentation, videos, procedural details, and subject reported outcomes would
      be collected. This data will be used for review and analysis to answer questions aimed in
      this study. Data collected from this study will be entered into a database that will be
      maintained for future research.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">October 2, 2018</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of participants with treatment-related adverse events as assessed by CTCAE v4.0</measure>
    <time_frame>01/01/2017-9/17/2018</time_frame>
    <description>Evaluate safety by assessment of adverse events of the novel minimally invasive treatment compared to invasive surgery.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient Reported Outcomes using the CONDUIT patient questionnaire.</measure>
    <time_frame>01/01/2017-9/17/2018</time_frame>
    <description>Evaluate efficacy by reviewing patient reported outcomes of the novel minimally invasive treatment compared to invasive surgery.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Achalasia</condition>
  <arm_group>
    <arm_group_label>POPE Patients</arm_group_label>
    <description>Patients who underwent POPE for end-stage achalasia, a sigmoid esophagus, or a redundant conduit that has been used to replace the esophagus.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>POPE</intervention_name>
    <description>Patients who have undergone Per-oral Plication of the Esophagus (POPE) procedure.</description>
    <arm_group_label>POPE Patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who have already undergone Per-oral Plication of the Esophagus (POPE) procedure
        for end-stage achalasia, a sigmoid esophagus, or a redundant conduit that has been used to
        replace the esophagus.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults &gt; 18 years of age

          -  Patients who have already undergone Per-oral Plication of the Esophagus (POPE)
             procedure

        Exclusion Criteria:

          -  Patients &lt;18 years of age
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shanda Blackmon</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic in Arizona</name>
      <address>
        <city>Scottsdale</city>
        <state>Arizona</state>
        <zip>85259</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic in Florida</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32224</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic in Rochester</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 18, 2019</study_first_submitted>
  <study_first_submitted_qc>March 13, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 14, 2019</study_first_posted>
  <last_update_submitted>February 14, 2020</last_update_submitted>
  <last_update_submitted_qc>February 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Shanda Blackmon, M.D., M.P.H.</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>POPE</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Esophageal Achalasia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

